|
Market Closed -
Nasdaq
16:00:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 14.12 USD | +2.54% |
|
-2.08% | -8.49% |
| 09-30 | Jade Biosciences, Inc. - Special Call | |
| 09-30 | Jade Biosciences, Inc. Announces Preclinical Data Characterizing Jade301 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 898M | - | - | - | - | - |
| 74.16B | |||||
| 57.39B | |||||
| 47.64B | |||||
| 44.29B | - | - | - | - | - |
| 42.5B |
Select your edition
All financial news and data tailored to specific country editions
